Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04579679
Title Open-Label Surufatinib in European Patients With NET
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Indications

neuroendocrine tumor

Therapies

Surufatinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU


No variant requirements are available.